Where can I easily buy Mifamutin injection in China?

Mifamurtide injection (Mifamurtide), trade name MEPACT, is an immunomodulatory anti-tumor drug used to treat non-metastatic osteosarcoma. Its mechanism of action is unique. Unlike traditional chemotherapy drugs, it does not directly kill cancer cells. Instead, it enhances the body's ability to remove tiny residual tumor cells by activating immune system components such as monocytes and macrophages, thereby delaying disease progression and reducing the risk of recurrence. The drug has been approved for marketing by the European Medicines Agency (EMA) and is used as one of the standard treatments in many European countries. It is often used in combination with chemotherapy to improve the long-term survival rate of patients with non-metastatic osteosarcoma.

Although mivamutide has a clear therapeutic status in European and American countries, it has not yet been approved for marketing in mainland China, nor has it been included in the national medical insurance directory. This means that the drug cannot be purchased directly through formal medical channels in China, such as hospital pharmacies or general pharmacies. Faced with this reality, many patients in need of treatment have to seek ways to purchase drugs overseas. Currently, the more common methods include compliant purchases through qualified international medical service platforms, cross-border e-commerce platforms or medical institutions.

It needs to be particularly emphasized that since mivamutide is a refrigerated storage drug with high requirements for transportation and storage, it is necessary to choose a qualified and formal platform to avoid drug failure or even side effects due to improper temperature control or unknown drug sources. In the future, as China gradually relaxes its policy on the import of new anti-cancer drugs, mivamutide is expected to accelerate the approval and introduction process in the country, bringing new treatment hope to more osteosarcoma patients. Prior to this, patients should reasonably evaluate the medication route under the guidance of a doctor to ensure that the treatment is safe, legal and compliant.

Reference materials:https://en.wikipedia.org/wiki/Mifamurtide